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Activation of TLR3 in Keratinocytes Increases
Expression of Genes Involved in Formation of the
Epidermis, Lipid Accumulation, and Epidermal
Organelles
Andrew W. Borkowski1, Kyungho Park2,3, Yoshikazu Uchida2,3 and Richard L. Gallo1,4
Injury to the skin, and the subsequent release of noncoding double-stranded RNA (dsRNA) from necrotic
keratinocytes, has been identified as an endogenous activator of Toll-like receptor 3 (TLR3). As changes in
keratinocyte growth and differentiation follow injury, we hypothesized that TLR3 might trigger some elements of
the barrier repair program in keratinocytes. dsRNA was observed to induce TLR3-dependent increases in human
keratinocyte mRNA abundance for ABCA12 (ATP-binding cassette, sub-family A, member 12), glucocerebrosidase,
acid sphingomyelinase, and transglutaminase 1. Additionally, treatment with dsRNA resulted in increases in
sphingomyelin and morphologic changes including increased epidermal lipid staining by Oil Red O and TLR3-
dependent increases in lamellar bodies and keratohyalin granules. These observations show that dsRNA can
stimulate some events in keratinocytes that are important for skin barrier repair and maintenance.
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INTRODUCTION
Rapid recovery of epidermal barrier function following injury
prevents water loss and opportunistic infection by infiltrating
microbes. Barrier repair after injury involves trafficking of
lamellar bodies (LBs) to the stratum corneum (SC), where they
secrete their contents (Menon et al., 1992), and activation of
several other genes, including the ATP-binding cassette sub-
family A, member 12 (ABCA12), an essential lipid transporter in
the epidermis responsible for harlequin ichthyosis (Akiyama
et al., 2005), and lamellar ichthyosis type 2 (Lefe´vre et al.,
2003), and lipid metabolism enzymes, glucocerebrosidase (GBA)
(Holleran et al., 1994) and acid sphingomyelinase (SMPD1)
(Jensen et al., 1999). Cholesterol (Menon et al., 1985a), free fatty
acid (Mao-Qiang et al., 1993; Ottey et al., 1995), and ceramide
synthesis all also increase following skin barrier disruption
(Holleran et al., 1991a, 1995) and are essential for barrier
repair. The mechanisms that regulate the complex events that
comprise barrier repair are incompletely defined, though a
calcium gradient in the epidermis plays an important role (Lee
et al., 1992; Menon et al., 1992a). In this study we sought to test
the hypothesis that double-stranded RNA (dsRNA), recently
discovered to be an endogenous product produced by epider-
mal injury following trauma or excess UVB exposure (Lai et al.,
2009; Bernard et al., 2012), might serve as a trigger for expression
of genes important to the epidermal barrier repair process.
dsRNA recognition can occur by several mechanisms
including binding to Toll-like receptor 3 (TLR3). TLR3 signal-
ing has largely been described as a recognition and response
system to combat viral infections (Kawai and Akira, 2008;
Dunleavy et al., 2010). Patients who have mutations in TLR3
(Zhang et al., 2007), UNC-93B, an endoplasmic reticulum
membrane protein important for its trafficking to the
endosome, (Casrouge et al., 2006), or TRIF (Toll/interleukin-1
receptor (TIR) domain-containing adapter-inducing IFN-b, a
key adaptor signaling molecule for TLR3 signaling (Sancho-
Shimizu et al., 2011), are more susceptible to herpes simplex
virus encephalitis. Thus, the importance of TLR3 in sensing
viruses is not disputed, although more recently it has been
shown to have an expanded role in a number of epithelial
tissues. For example, inflammatory cytokines are induced by
RNA released during necrosis in the gut (Cavassani et al.,
2008) or damage to the skin (Lai et al., 2009; Bernard et al.,
2012). In addition, recent publications have also demonstrated
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that TLR3 is important for wound healing, as Tlr3 /
mice have a slightly delayed wound healing phenotype
(Lin et al., 2011), whereas Polyinosinic acid:Polycytidylic
acid (Poly(I:C)), a dsRNA analog and ligand for TLR3, can
promote wound healing in mice (Lin et al., 2012).
These recent findings suggest that TLR3 may have multiple
functions in the skin and may signal the start of barrier repair
processes in addition to its role in viral defense. We show
herein that TLR3 activation increased expression of genes
critical to barrier formation, increased the appearance of
epidermal lipids, and increased LBs and keratohyalin granules
(KHGs), important elements of the epithelial barrier repair
response. These findings therefore identify TLR3 as a potential
regulator of epidermal regeneration following injury.
RESULTS
Gene expression profiling of lipid metabolism and lipid
transporter pathways
To identify gene expression pathways in addition to the known
inflammatory response associated with TLR3 activation of
keratinocytes, we examined the transcriptome of normal
human epidermal keratinocytes (NHEKs) 24 hours after expo-
sure to the dsRNA Poly(I:C). In response to Poly(I:C), a total of
5,542 differentially regulated genes changed by at least 2-fold
(2,773 upregulated and 2,769 downregulated; Significance
Analysis of Microarrays (SAM): triplicate; false discovery rate
o0.01%; delta value¼ 1.397; Supplementary Figure S1a
online). These genes were further analyzed using the Database
for Annotation, Visualization and Integrated Discovery
(DAVID) (Huang et al., 2009a, b). This analysis suggested
that Poly(I:C) affected a number of pathways involved in
lipid metabolism and transport. Specifically, changes were
observed in the expression of genes in glycosphingolipid
biosynthesis, ABC transporters, sphingolipid metabolism, and
other lipid biosynthesis/metabolism and inflammatory
pathways (Figure 1a). Several specific genes identified by this
approach are known to play a role in maintaining or forming
the skin barrier, such as ABCA12 (3.74-fold), GBA (2.02-fold),
SMPD1 (2.04-fold), transglutaminase 1 (TGM1; 2.40-fold), as
well as tumor necrosis factor (TNF; 5.31-fold), IL-6 (27.31-
fold), and TLR3 (14.58-fold). Involucrin, loricrin (LOR), keratin 1
(KRT1), keratin 14 (KRT14), and filaggrin (FLG), markers of
epidermal differentiation, were not increased significantly
(Figure 1b). The results of the microarray showed that genes
involved in synthesis of ceramides (UGCG, SPTLC1, SPTLC2),
free fatty acids (ACACA and FASN), and cholesterol (FDFT1,
HMCCR, and HMGSC1) were not significantly altered other
than acetyl CoA carboxylase (ACACA; 0.33-fold).
Poly(I:C) enhances transcript abundance of genes involved in
skin barrier formation
To validate the results of the gene expression profile of
Poly(I:C)-treated NHEKs, we measured a number of genes by
real-time PCR. mRNA of ABCA12, GBA, SMPD1, and TGM1
were significantly upregulated following treatment with
Poly(I:C) (Figure 2a and Table 1). As expected, traditional
inflammatory markers TNF, IL-6, and TLR3 were also upregu-
lated (Figure 2b and Table 1). Consistent with microarray data,
this treatment did not induce expression of involucrin, KRT1,
LOR, FLG, or KRT14 (Figure 2c and Table 1). Interestingly,
Poly(I:C) treatment significantly induced expression of mRNA
for ceramide synthesis enzymes, including serine palmitoyl-
transferase (SPTLC1 and SPTLC2) and glucosylceramide
synthase (UGCG) (Figure 1b and Table 1). Ligands for TLRs
2, 7, 8, and 9 did not significantly alter expression of these
barrier repair genes (Supplementary Figure S2a and b online).
A dose-dependent increase in the mRNA levels of ABCA12,
GBA, SMPD1, TNF, and IL-6 was observed following treat-
ment with Poly(I:C), with maximal expression seen after
treatment with 0.5 to 1mg ml1 Poly(I:C) (Figure 2d). Increases
in transcript abundance for ABCA12, GBA, and SMPD1 were
not seen until 24 hours after treatment, whereas TNF expres-
sion increased more rapidly and was maximal at 1 hour
(Figure 2e). However, the latter effect on gene expression
was not because of induction of these cytokines as treatment
of NHEKs with TNF or IL-6 had no significant effect on the
induction of ABCA12, GBA, or SMPD1 mRNA levels
(Figure 2e).
TLR3 activation is required for dsRNA-induced changes in gene
expression
To determine if the increases in ABCA12, GBA, SMPD1, and
TGM1 mRNA after Poly(I:C) treatment were dependent
on TLR3 activation, we used small interfering RNA to knock-
down TLR3 in NHEKs. When TLR3 was significantly
decreased in keratinocytes, Poly(I:C) failed to induce a
significant increase in mRNA for the barrier repair genes
ABCA12, GBA, SMPD1, TGM1, and TNF (Figure 3a). As TLR3
signaling is dependent on proper acidification and maturation
of endosomes (Matsushima et al., 2004), we used Bafilomycin
A1 (BafA1), a specific inhibitor of the V-type ATPase required
for acidification of endosomes and lysosomes, to inhibit
TLR3 signaling. BafA1 blocked Poly(I:C)-induced increases
in ABCA12, GBA, and SMPD1 mRNA as well as increases
in mRNA of the inflammatory cytokines TNF and IL-6
(Figure 3b). Similar effects on gene expression were seen
when TRIF, a key signaling molecule downstream of TLR3,
was knocked down (Supplementary Figure S4 online). Unlike
silencing of TLR3 or TRIF, knocking down MAVS, a key
signaling molecule for RIG-I-like receptors that recognizes
cytosolic dsRNA, had no significant effect on Poly(I:C)-
induced expression of ABCA12, GBA, SMPD1, and TGM1
(Supplementary Figure S5 online). Although TLR3 activation
was important for Poly(I:C)-induced increases in UGCG
mRNA, alterations in mRNA for several lipid synthesis genes
was largely independent of TLR3 (Figure 3c).
Activation of TLR3 alters epidermal lipid content
To determine whether increases in ABCA12, GBA, and
SMPD1 transcripts were paralleled by changes in epidermal
lipid composition, we first stained for the presence of lipid in
NHEKs grown in differentiating conditions. A large increase in
Oil Red O-staining bodies was seen when NHEKs were
exposed to Poly(I:C) for 72 hours (Figure 4a). A significantly
higher expression of ABCA12 and GBA was also seen upon
Poly(I:C) treatment under these conditions (Supplementary
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Figure S3a and b online). Lipids were then quantified by
measuring the amount of Oil Red O dye that was retained
after staining and normalizing this to total protein. Poly(I:C)
treatment induced significant increases in lipids stained by Oil
Red O at days 1–3 (Figure 4b). Next, three-dimensional (3D)
skin constructs were exposed to Poly(I:C) to determine the
response of stratified and differentiated keratinocytes that
model the epidermis but are not influenced by the presence
of resident or recruited leukocytes that would be present
in vivo. In these 3D skin constructs, the SC of Poly(I:C)-treated
Gene
IL-6 0.95
0.96
1.05
0.88
1.07
1.02
0.98
1.04
0.91
1.26
0.98
0.96
1.08
1.04
0.92
1.00
1.04
0.95
0.92
1.03
0.89 1.06 1.05 0.30 0.34 0.35
1.07 0.90 0.48 0.70 0.37
1.07 1.01 0.48 0.65 0.66
1.02 1.03 0.58 0.72 0.71
0.96 1.00 0.75 0.60 0.66
1.03 0.97 0.77 0.82 0.84
0.99 1.10 0.90 0.79 0.82
0.93 1.03 0.85 0.80 0.89
1.00 0.93 1.07 1.08 0.91
1.03 1.01 0.93 1.05 1.13
1.04 0.99 1.17 1.20 1.19
0.84 0.90 2.28 1.37 0.95
1.06 1.03 1.22 1.65 1.93
0.97
0.97
1.05
1.00
1.95
1.82 1.63 1.63
1.97 2.16
0.91 1.07 1.93 1.98 2.23
1.02 0.91 2.31 2.50 2.38
1.03 1.09 3.03 3.46 4.73
0.88 1.07 4.79 5.43 5.70
1.00 1.04 13.14 14.80 15.80
0.92 1.13 16.45 21.09 35.75
TLR3
TNF
ABCA12
TGM1
SMPD1
GBA
MAVS
HMGCS1
LOR
SPTLC1
HMGCR
KRT14
FDFT1
FLG
SPTLC2
FASN
UGCG
IVL
KRT1
ACACA
Control
Fold change
0.2 1 5
+ 1 μg ml–1 Poly(I:C)
KEGG pathwaysa
b
Cytokine-cytokine receptor interaction
Toll-like receptor signaling pathway
Chemokine signaling pathway
Glycosphingolipid biosynthesis
Endocytosis
Sphingolipid metabolism
Glycerophospholipid metabolism
ABC transporters
Biosynthesis of unsaturated fatty acids
Fatty acid metabolism
Glycerolipid metabolism
Induced
Repressed
Linoleic acid metabolism
DNA replication
Cell cycle
Mismatch repair
Nucleotide excision repair
Pyrimidine metabolism
Purine metabolism
Wnt signaling pathway
0.01 0.1 1 10
P-value (-log10)
100
Figure 1. Gene expression profiling of normal human epidermal keratinocytes (NHEKs) identifies upregulation of genes involved in lipid biosynthesis,
metabolism, and transporter pathways following treatment with double-stranded RNA (dsRNA). (a) Significantly changed genes analyzed using the Database
for Annotation, Visualization and Integrated Discovery (DAVID) to identify significant pathways (EASE¼1.0). (b) Genes involved in skin barrier formation and
dsRNA recognition. KEGG, Kyoto Encyclopedia of Genes and Genomes; Poly(I:C), polyinosinic acid:polycytidylic acid.
AW Borkowski et al.
TLR3 Activation Induces Barrier Repair Genes
www.jidonline.org 2033
samples stained more strongly for Oil Red O compared with
control samples (Figure 4c).
To measure the response of specific lipid components
produced by cultured keratinocytes, total lipids were isolated
from NHEKs after Poly(I:C) treatment and resolved using high-
performance thin-layer chromatography. Sphingomyelin was
significantly increased following Poly(I:C) treatment and this
increase was blocked following small interfering RNA silen-
cing of TLR3 (Figure 4d). Glucosylceramide levels were
significantly decreased after Poly(I:C) treatment, although this
change was independent of TLR3 (Figure 4e). Ceramides
increased following Poly(I:C) treatment, although this increase
was not abolished by knockdown of TLR3 (Figure 4f). Cho-
lesterol levels were not significantly altered after Poly(I:C)
treatment in either control or TLR3 knockdown keratinocytes
(Figure 4g).
TLR3 activation increases the quantity of LBs and KHGs in the
epidermis
As we observed increases in the staining of lipids following
exposure to dsRNA, we next sought to determine if other
morphological changes in keratinocytes could be observed by
electron microscopy. To assess this, we quantitated the
number of LBs and KHGs in the upper stratum granulosum
in 3D epidermal skin constructs. Skin constructs treated with
Poly(I:C) had significantly more LBs and KHGs (Figure 5a and
b). The observed increases in LBs and KHGs were dependent
on TLR3, as skin constructs generated from TLR3-knockdown
NHEKs failed to exhibit significant increases in LBs and KHGs
when exposed to Poly(I:C) (Figure 5c).
DISCUSSION
TLR activation is classically considered to result in proinflam-
matory responses. In this study, we demonstrate that TLR3
activation of keratinocytes also leads to changes in expression
of some genes in keratinocytes that are associated with
epidermal structure. An increase in transcript abundance of
ABCA12, GBA, SMPD1, and TGM1 occurred in a TLR3-
dependent manner. This response was followed by increases
in epidermal lipid accumulation as well as increases in the
abundance of LBs and KHGs in epidermal equivalents. These
observations are consistent with recent observations that
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Figure 2. Polyinosinic acid:polycytidylic acid (Poly (I:C)) enhances transcript abundance of genes involved in skin barrier formation. Normal human
epidermal keratinocyte (NHEKs) were cultured in the presence of 1mg ml 1 Poly(I:C) for 24 hours. Real-time PCR was used to quantify mRNA levels and fold
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dsRNA is released by damaged cells and can serve as a
damage-associated molecular pattern. Thus, we now show
that skin epithelial cells initiate some of the events associated
with barrier repair after recognition of dsRNA.
The protective properties of the skin barrier reside in the SC
and are heavily dependent on the lipid-rich lamellar mem-
branes surrounding differentiated keratinocytes (Holleran
et al., 1991b; Feingold, 2007; Feingold and Denda, 2012).
Previous studies have characterized the barrier repair
response, delineating the increase in epidermal lipid
synthesis and metabolism in the skin (Menon et al.,
1985a; Feingold, 1991; Holleran et al., 1991a,b) and
secretion of LBs following barrier disruption (Menon et al.,
1992b). Because our current observations show TLR3
activation is accompanied by increases in mRNA-encoding
genes involved in epidermal formation, accumulation of
epidermal lipids, and formation of epidermal organelles, we
provide evidence that TLR3 may be a previously unknown
mechanism by which keratinocytes detect epidermal injury
and initiate some of the steps involved in formation of a
functional skin barrier. However, as mice lacking TLR3 appear
to develop normally, this recognition system is not critical to
normal development. Furthermore, although many Poly(I:C)-
induced changes in lipid composition and quantity were
observed, not all of these changes were TLR3 dependent. It
is important to keep in mind that we did not observe a global
upregulation in lipid or differentiation markers. In contrast, we
observed that dsRNA can induce TLR3-dependent changes
only in specific elements involved in the process of repair.
How these responses combine into the complete barrier repair
program remain to be determined.
A number of receptors are known to recognize and respond
to dsRNA (Yu and Levine, 2011), making it important to
determine whether TLR3 activation was required for the gene
expression changes seen in response to dsRNA. Using both
RNA silencing and pharmacological inhibition, we
demonstrated that increases in skin barrier genes in response
to Poly(I:C) were dependent on TLR3. As the Poly(I:C)-induced
changes in mRNA of these barrier genes were almost
completely abrogated when TLR3 activation was silenced,
our data suggest that TLR3 activation is required for the
observed changes. These data do not rule out the
contribution of cytoplasmic sensors of dsRNA that exist in
the cell, including RIG-I, MDA5, PKR, and NLRP3, although
the failure of MAVS knockdown to partially inhibit the
Poly(I:C) response argues against a role for cytoplasmic RNA
recognition. Thus, the relevance of these sensors in
keratinocytes is yet to be clearly defined.
As changes in gene expression are not seen until 24 hours
after Poly(I:C) treatment, it is possible that the change in
transcription of ABCA12, GBA, SMPD1, and TGM1 is not a
direct downstream transcriptional event of TLR3 activation,
but rather an autocrine or paracrine effect dependent on
synthesis of intermediate genes. TNF and IL-6 are produced
following TLR3 activation and have been shown to improve
the skin barrier (Jensen et al., 1999; Wang et al., 2004).
Therefore, we also examined the direct effects of these
cytokines on induction of the barrier genes of interest. As no
changes in gene expression of ABCA12, GBA, or SMPD1 were
observed with TNF or IL-6 treatment of keratinocytes under
conditions similar to those where Poly(I:C) did induce these
cytokines, it is unlikely that these cytokines acting alone are
responsible for the observed effects. Future work will seek to
better understand the factors responsible for transcriptional
regulation of ABCA12, GBA, SMPD1, and TGM1 by TLR3,
with specific interest in determining if these genes represent an
immediate canonical response to TLR3 or are activated in
response to stimulation of intermediate factors that may
function in an autocrine manner.
Poly(I:C) recognition by TLR3 in keratinocytes appears to be
functionally relevant. Sphingolipids, such as ceramides and its
precursors sphingomyelin and glucosylceramides, are essen-
tial for the formation and maintenance of the skin barrier
(Holleran et al., 1991a). Poly(I:C)-treated keratinocytes
displayed a rapid appearance of lipid-containing vesicles
and an increase in ceramides. More intense lipid staining in
the SC was also observed in 3D skin constructs treated with
Table 1. Poly(I:C)-induced gene expression changes
Gene
name
Fold change
(real-time PCR) ±SD t-Test
Fold change
(microarray) SAM
ABCA12 22.68 5.551 ** 3.74 þ
GBA 10.84 1.243 *** 2.03 þ
SMPD1 9.48 1.143 *** 2.05 þ
TGM1 30.65 4.231 *** 2.40 þ
TNF 23.07 0.564 *** 5.31 þ
IL-6 41.99 2.480 *** 27.31 þ
TLR3 69.66 9.100 *** 14.58 þ
MAVS 1.40 0.309 NS 1.70 
KRT1 1.33 1.727 NS 0.52 
KRT14 0.74 0.012 *** 1.02 
IVL 0.79 0.064 NS 0.60 
LOR 1.43 1.216 NS 1.53 
FLG 0.83 1.224 NS 0.84 
SPTLC1 1.36 0.071 ** 1.19 
SPTLC2 3.72 0.834 ** 0.81 
UGCG 2.61 0.174 *** 0.67 
ACACA 0.37 0.079 ** 0.33 þ
FASN 0.48 0.113 * 0.67 
HMGCR 1.24 0.057 * 1.04 
HMGCS1 1.07 0.143 NS 1.60 
FDFT1 0.71 0.096 * 0.85 
Abbreviations: NS, nonsignificant; Poly(I:C), polyinosinic acid:polycytidylic
acid; SAM, Significance Analysis of Microarrays.
*Po0.05,**Po0.01, and ***Po0.001. Student’s t-test.
Data are mean of triplicate samples and representative of at least three
independent experiments for real-time PCR. Data are mean of triplicate
samples and analyzed for significance with SAM (fold change 42, false
discovery rate (FDR) o0.01%; delta value¼ 1.397).
Data in table represent real-time PCR and microarray fold change data
from normal human epidermal keratinocyte (NHEKs) treated with
1mg ml1 Poly(I:C) versus control, water-treated NHEKs.
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Poly(I:C). In addition, sphingomyelin levels were increased by
Poly(I:C) treatment in a TLR3-dependent manner. In contrast,
levels of glucosylceramides decreased following Poly(I:C)
treatment, but not in a TLR3-dependent manner. These
observations confirmed the importance of TLR3 activation in
perturbing epidermal lipid levels, but suggest that other
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Figure 3. Toll-like receptor 3 (TLR3) activation is required for double-stranded RNA (dsRNA)-induced changes in gene expression. (a) TLR3 was silenced in
normal human epidermal keratinocytes (NHEKs) for 48 hours before treatment with 1mg ml1 polyinosinic acid:polycytidylic acid (Poly(I:C)) for 24 hours.
Real-time PCR was used to quantify mRNA levels and fold change values are calculated relative to and normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) expression. Two-tailed t-test. (b) NHEKs were treated with 5 nM Bafilomycin A1 for 1 hour before treatment with 1mg ml1 Poly(I:C) for 24 hours.
One-way analysis of variance (ANOVA). (c) TLR3 was silenced in NHEKs for 48 hours before treatment with 1mg ml 1 Poly(I:C) for 24 hours. Real-time PCR was
used to quantify mRNA levels and fold change values are calculated relative to and normalized to GAPDH expression. *Po0.05; **Po0.01; ***Po0.001.
NS, nonsignificant. Two-tailed t-test. Data are mean±SEM, n¼3, and are representative of at least three independent experiments.
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pathways influenced by the addition of Poly(I:C) also
contribute to the response of some lipids. It remains to be
determined whether Poly(I:C) treatment of NHEKs can
stimulate de novo lipid synthesis. As our mRNA data of a
number of lipid metabolism genes show that dsRNA can alter
these transcripts, it is possible that the enzyme activity could
also be altered, but this remains to be explored. As Oil Red O–
positive vesicles most likely contain a mix of nonpolar lipids,
we do not believe that the TLR3-dependent increases in
sphingomyelin are being detected in those experiments, rather
other lipid species that have yet to be identified. Future studies
will hopefully elucidate whether de novo lipid synthesis is
occurring and which additional lipid species are increased in
a TLR3-dependent manner.
To further investigate functional changes in keratinocytes
following Poly(I:C) treatment, we examined ultrastructural
changes in keratinocytes within 3D skin constructs. Treatment
of keratinocytes with Poly(I:C) yielded a higher amount of both
LBs and KHGs in the granular layer of the epidermis. Although
LBs have been found to be depleted in the granular layer
following barrier disruption due to their rapid trafficking and
secretion of barrier components (Menon et al., 1992b), they
are rapidly regenerated to aid in future barrier repair as well as
proper differentiation and barrier formation. We speculate that
TLR3 activation by endogenous dsRNA could be an initiation
event that leads to downstream effects of epidermal lipid
production, trafficking, and metabolism. Increases in KHGs
also provide further evidence that Poly(I:C) treatment could
promote barrier formation or repair as KHGs also contain
essential barrier components of the SC including profilaggrin
and LOR. Though we do not see increases in transcripts of
FLG and LOR after Poly(I:C) treatment, the increased presence
of KHGs provides evidence suggesting that dsRNA can
influence barrier formation.
We believe that this work identifies a key recognition event
that could trigger some elements of skin barrier formation
during the process of repair. How this recognition event is
propagated after TLR3 activation remains to be determined.
However, these results could be utilized in the treatment of
certain dermatological diseases such as atopic dermatitis (AD).
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For years, it has been known that AD patients have signifi-
cantly decreased ceramide levels in the SC (Melnik et al.,
1988; Yamamoto et al., 1991). Although some recent studies
have shown AD to be associated with FLG mutations (Palmer
et al., 2006), a number of reports cite and characterize cases
of AD that are independent of FLG mutations (Jasaka et al.,
2011) and demonstrate that AD patients have abnormal
ceramide profiles and lamellar lipid organization (Ishikawa
et al., 2010; Janssens et al., 2011). From our research, it could
be speculated that this deficiency of ceramides in the SC of
AD patients could be treated by pharmacological activation of
pathways downstream of TLR3, thus leading to increases in
ceramides. Of course, many unwanted inflammatory side
effects may result from TLR3 activation, and hence it will be
important to determine specifically which pathways
downstream of TLR3 are involved in the increase of
epidermal lipids. By examining these downstream pathways,
we may also discover more about the regulatory events
involved in ceramide biosynthesis and metabolism that
could be affected in AD patients. Future studies will involve
identifying and characterizing these downstream pathways of
TLR3 activation relevant to barrier repair.
MATERIALS AND METHODS
Cell culture and stimuli
NHEKs were obtained from Cascade Biologics/Invitrogen (catalog
number: C-001-5C; Portland, OR), and grown in serum-free EpiLife
cell culture media (Cascade Biologics/Invitrogen) containing 0.06 mM
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Figure 5. Toll-like receptor 3 (TLR3) activation increases the quantity of lamellar bodies (LBs) and keratohyalin granules (KHGs) in the epidermis.
(a) Transmission electron microscopy of three-dimensional (3D) skin construct treated with 1mg ml1 polyinosinic acid:polycytidylic acid (Poly(I:C)) for 72 hours.
Arrows indicate LBs and arrowheads indicate KHGs. Bar¼ 1mm. SC, stratum corneum; SG, stratum granulosum. (b) Quantification of LBs and KHGs.
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Ca2þ and 1 EpiLife Defined Growth Supplement (EDGS, Cascade
Biologics/Invitrogen) at 37 1C under standard tissue culture condi-
tions. All cultures were maintained for up to eight passages in this
medium with the addition of 100 U ml 1 penicillin, 100mg ml–1
streptomycin, and 250 ng ml 1 amphotericin B. Cells at 60–80%
confluence were treated with Bafilomycin A1 (5 nM; Sigma, St Louis,
MO), poly(I:C) (1mg ml 1; Invivogen, San Diego, CA), IL-6
(10 ng ml–1; R&D Systems, Minneapolis, MN), or TNF-a (50 ng ml–1;
Chemicon, Temecula, CA) in 12-well flat-bottom plates (Corning
Incorporated Life Sciences, Lowell, MA) for up to 24 hours. After cell
stimulation, RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA). RNA was stored at  80 1C.
For visualization or analysis of lipids, cells were switched to
advanced-stage differentiation media (DMEM/F-12 (2:1), 10% fetal
bovine serum (Invitrogen), 400 ng ml 1 hydrocortisone (Sigma),
10mg ml 1 human recombinant insulin (Sigma), and freshly made
50mg ml 1 ascorbic acid (Sigma)) for 24 to 72 hours during stimula-
tion. Media was changed every other day and prepared with freshly
dissolved, filter-sterilized vitamin C.
Quantitative real-time PCR
Total RNA was extracted from cultured keratinocytes using TRIzol
Reagent (Invitrogen) and 1mg RNA was reverse-transcribed using
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Pre-developed
Taqman Gene Expression Assays (Applied Biosystems, Foster City,
CA) were used to evaluate mRNA transcript levels of ABCA12, GBA,
SMPD1, TGM1, TNF, IL-6, KRT1, KRT14, involucrin, FLG, LOR, and
TLR3. Glyceraldehyde-3-phosphate dehydrogenase mRNA transcript
levels were evaluated using a VIC-CATCCATGACAACTTTGGTA-
MGB probe with primers 50-CTTAGCACCCCTGGCCAAG-30 and
50-TGGTCATGAGTCCTTCCACG-30. All analyses were performed in
triplicate and were representative of three to five independent cell
stimulation experiments that were analyzed in an ABI Prism 7000
Sequence Detection System (Life Technologies, Carlsbad, CA). Fold
induction relative to glyceraldehyde-3-phosphate dehydrogenase was
calculated using the DDCt method. Results were considered to be
significant if Po0.05.
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